Table 5.

Univariate analysis of patients’ 5 year overall survival based on the pre-NAC status of the markers.

Variable	Person-Year	Event	HR (95% CI)	p
pre-NAC MLKL
Low	86	10	ref
High	88	8	0.80 (0.31–2.03)	0.638
pre-NAC pMLKL
Low	137	11	ref
High	38	7	2.17 (0.84–5.64)	0.111

Abbreviations: HR, hazard ratio; CI, confidence interval; NAC, neoadjuvant chemotherapy; MLKL, mixed lineage kinase domain-like protein; pMLKL, phosphorylated MLKL.